Latest Articles
What are ‘tissue ACE inhibitors,’ and should they be used instead of other ACE inhibitors?Improvement in surrogate end points may not necessarily translate into improvement in “hard” clinical end points.
- Shedding: How to manage a common cause of hair loss
Shedding is not a disease, but it sometimes is a sign of a disease.
- Evolving cardiovascular applications for magnetic resonance imaging
Improvements in MRI have increased its value in existing cardiovascular applications and opened the door to new uses.
- Managing menopause after breast cancer: Balancing risks and benefits
One of the most complex issues facing breast cancer survivors and their physicians is how to manage menopause.
- A 35-year-old man with recurrent aseptic meningitis
What is the cause of this patient’s symptoms? A self-test on a clinical case.
- Phenylpropanolamine and stroke: The study, the FDA ruling, the implications
The FDA, after a recent study, asked manufacturers to pull dozens of products from the shelves.
- Making the most of cholesterol-lowering margarines
These new “functional foods” reduce serum cholesterol and LDL levels modestly when used instead of regular margarine, butter, or oil. Are they worth it?
- Rare but serious adverse effects in commonly used drugs
Some adverse effects come to light only after millions of people have taken a drug.
- Management of asymptomatic left ventricular dysfunction
Heart failure can have an insidious onset, and the best time to intervene with ACE inhibitors and beta-blockers is early.
